fda_recall · drug_recall · high

Direct Rx — Class II recall: DULOXETINE D/R, a) 30 mg (NDC 61919-482-30), 30 Caps; b) 30 mg (NDC 61919-482-60…

Event date
2026-07-01 00:00:00Z
Observed
2026-07-09 22:51:31Z
Source ID
D-0617-2026
Payload hash
cc25fcadfba94488e25fea8f

Summary

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit Status: Ongoing.

Entities

Informational only. Not legal, financial, or medical advice.